Search results

Jump to navigation Jump to search
  • ...wth factor]] that activates the Axl [[receptor (biochemistry)|receptor]] [[tyrosine kinase]] and stimulates cell proliferation or prevents [[apoptosis]] in some cells
    9 KB (1,333 words) - 07:35, 9 June 2009
  • ...stimulation of the receptor, is a cause for the disease. Inhibiting the [[tyrosine kinase]] receptor with [[imatinib]] (see below) may reduce the symptoms of mastocy
    13 KB (1,802 words) - 09:02, 1 March 2024
  • ...for a receptor without the intraceullar C terminal, which is necessary for tyrosine kinase activation. Only one family have been found to have a leptin receptor muta
    21 KB (3,145 words) - 15:26, 25 February 2023
  • ...15800324}}</ref> A small pilot study suggested possible benefit from the [[tyrosine kinase]] inhibitor [[erlotinib]] in patients with advanced cholangiocarcinoma.<ref
    46 KB (6,423 words) - 06:04, 5 April 2024
  • ...protein Shank3 mediates signaling and biological function of the receptor tyrosine kinase Ret in epithelial cells] G. Schuetz et al (2004) Journal of Cell Biology. V
    49 KB (7,285 words) - 04:27, 20 January 2011
  • ...nsmissivity]], [[Treehouse]], [[Tropic]], [[Troposphere]], [[Trospium]], [[Tyrosine Kinase]], [[Ulysses S. Grant]], [[United States v. Lopez]], [[Unit (military)]], [
    45 KB (4,912 words) - 07:29, 24 April 2024
View ( | next 20) (20 | 50 | 100 | 250 | 500)